Source: American Cancer Society
Date: March 13, 2007
Summary:
The American Cancer Society reports on the development of a new drug treatment for graft-versus-host disease (GVHD), a side-effect of stem cell transplants:
"A new steroid pill could help tame one form of graft-versus-host disease (GVHD), a complication of the stem cell transplants some cancer patients need. In a recent study, patients who got the pill had fewer flare-ups of GVHD in their stomach and intestine and had a lower risk of dying one year after their transplant."
